Khalid Islam - Jun 24, 2025 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Role
Director
Signature
/s/ Khalid Islam
Stock symbol
GANX
Transactions as of
Jun 24, 2025
Transactions value $
$0
Form type
4
Date filed
6/25/2025, 05:30 PM
Previous filing
Jun 4, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Islam Khalid Director C/O GAIN THERAPEUTICS, INC., 4800 MONTGOMERY LANE, SUITE 220, BETHESDA /s/ Khalid Islam 2025-06-25 0001701858

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GANX Stock Option (right to buy) Award $0 +15K $0.00 15K Jun 24, 2025 Common Stock 15K $1.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 12 equal monthly installments commencing on July 24, 2025, subject to the Reporting Person's continuous service through the applicable vesting date.